Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain
Clinical trial NCT04630990 · COMPLETED
Trial details
- NCT number
- NCT04630990
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-14
- Primary completion
- 2024-03-26
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.